The CAPRA-S score versus subtypes of minimal residual disease to predict biochemical failure after radical prostatectomy

Documenti analoghi

• Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy
  di: Murray, Nigel P, et al.
  Pubblicazione: (2019)
• The CAPRA score versus sub-types of minimal residual disease to predict biochemical failure after external beam radiotherapy
  di: Murray, Nigel P, et al.
  Pubblicazione: (2020)
• The Epstein criteria predict for organ-confined prostate cancer but not for minimal residual disease and outcome after radical prostatectomy
  di: Murray, Nigel P., et al.
  Pubblicazione: (2020)
• Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone
  di: Murray, Nigel P, et al.
  Pubblicazione: (2020)
• Minimum Residual Disease in Patients Post Radical Prostatectomy for Prostate Cancer: Theoretical Considerations, Clinical Implications and Treatment Outcome
  di: Murray, Nigel P, et al.
  Pubblicazione: (2018)